Nabriva Therapeutics plc

OTCPK:NBRV.F Stock Report

Market Cap: US$323.0

Nabriva Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NBRV.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions5650.0175%
Individual Insiders13,7040.424%
VC/PE Firms180,5045.59%
General Public3,036,06494%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 11 shareholders own 6.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.59%
Lincoln Park Capital, LLC
180,504US$18.00%no data
0.26%
Theodore Schroeder
8,483US$0.80%no data
0.042%
Colin Broom
1,369US$0.10%no data
0.041%
Steven Gelone
1,323US$0.10%no data
0.019%
Charles Rowland
610US$0.060%no data
0.017%
BBVA Asset Management, S.A., S.G.I.I.C
565US$0.060%no data
0.014%
Stephen Webster
456US$0.050%no data
0.013%
Daniel Burgess
415US$0.040%no data
0.012%
Carrie Bourdow
396US$0.040%no data
0.011%
Lisa Dalton
364US$0.040%no data
0.0089%
Mark H. Corrigan
288US$0.030%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.